See Tai Sandi 4
4 · Lexeo Therapeutics, Inc. · Filed Apr 9, 2025
Insider Transaction Report
Form 4
See Tai Sandi
Chief Development Officer
Transactions
- Award
Common Stock
2025-03-14$2.61/sh+5,720$14,929→ 59,609 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- [F2]Includes 51,218 restricted stock units.